InforMax Announces GenoMax License Agreement With Windber Research Institute.Business Editors BETHESDA, Md.--(BUSINESS WIRE)--July 31, 2001 InforMax, Inc. (Nasdaq:INMX), a leading global provider of bioinformatics software solutions, today announced that in the second quarter ending June 30, 2001 it signed a license agreement with the Windber Research Institute This article has multiple issues: * It needs sources or references that appear in third-party publications. * It reads like an advertisement and needs to be rewritten in a neutral point of view. (Windber, PA) for the GenoMax(TM) enterprise software system. This agreement includes software license, system support, and professional services. Rapidly becoming an industry standard, GenoMax is an enterprise bioinformatics system that supports High-Throughput Research(TM) (HTR HTR Heater HTR High Temperature Reactor HTR Hard-To-Reach HTR Hunter: the Reckoning (White-Wolf game) HTR Hemolytic Transfusion Reaction (blood transfusion) HTR Hellenic Technology of Robotics ), InforMax's process for minimizing the time and cost of both discovering and validating valuable targets for pharmaceutical, therapeutic, and diagnostic development. GenoMax is a modular family of analysis programs designed to work with one or more types of genomic and proteomic data including sequence information, gene expression data, protein structure, and protein-protein interactions. The GenoMax enterprise platform is used by more than 30 biopharmaceutical companies worldwide to leverage InforMax's data mining and analysis capabilities. "Managing and mining experimental data is critical to an improved understanding of disease processes. InforMax is pleased to have been selected by the Windber Research Institute as the solution provider to enable their discovery research efforts in the area of breast cancer," said Alex Titomirov, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of InforMax. Windber Research Institute is an offsite research laboratory for the Clinical Breast Care Project (CBCP CBCP Catholic Bishops Conference of the Philippines CBCP Certified Business Continuity Professional (Disaster Recovery Institute International) CBCP Callback Control Protocol CBCP Certified Business Continuity Planner ) of the Walter Reed Army Medical Center Walter Reed Army Medical Center, major hospital complex in Washington, D. C., and Forest Glen, Md.; est. 1923 and named for U.S. army surgeon Walter Reed. It is composed of seven units including a general hospital and a research institute. There are several thousand beds. , Washington, DC. "We look forward to working with Windber to implement our software and provide the professional services to ensure their success." The Windber Research Institute (WRI WRI Wolfram Research, Inc. (makers of Mathematica) WRI World Resources Institute WRI War Resisters' International WRI Western Research Institute (Laramie, WY) WRI Water Research Institute ) is currently one of the only fully integrated research facilities designed from the onset to be a national tissue repository linked to a functional genomics and proteomics laboratory and equipped for high throughput parallel characterization of tissue specimens to generate biologically relevant information at the DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic and protein levels. Mr. Nick Jacobs, President/CEO of Windber Medical Center and Windber Research Institute, said he is happy to be associated with InforMax, an industry leader in bioinformatics. "We believe that this association will be the beginning of mutually beneficial collaborations between Informax and the Windber Research Institute." LTC LTC abbr. lieutenant colonel Craig Shriver shrive v. shrove or shrived, shriv·en or shrived, shriv·ing, shrives v.tr. 1. To hear the confession of and give absolution to (a penitent). 2. MD, FACS FACS Fellow of the American College of Surgeons. FACS abbr. Fellow of the American College of Surgeons FACS fluorescence-activated cell sorter. , Chief of General Surgery and CBCP Program Director, Walter Reed Army Medical Center, believes that GenoMax will provide the genome analysis and data mining solutions needed by the CBCP for better understanding of the genetic basis for breast cancer. About Windber Research Institute The Windber Research Institute (WRI) is a newly established state of the art biomedical research organization in scenic western Pennsylvania. WRI, which is funded through the Henry M. Jackson “Scoop Jackson” redirects here. For the basketball writer, see Scoop Jackson (writer). Henry Martin "Scoop" Jackson (May 31, 1912 – September 1, 1983) was a U.S. Congressman and Senator for Washington State from 1941 until his death. Foundation, Rockville, MD, was established to conduct functional genomics and proteomics research for the comprehensive Clinical Breast Care Project (CBCP) of Walter Reed Army Medical Center (WRAMC WRAMC Walter Reed Army Medical Center ), Washington DC and the Joyce Murtha Breast Care Center (JMBCC), Windber, PA. WRI is using a variety of biological, bioimaging, high-density cDNA and protein profiling, Laser capture micro dissection and computational tools to carry out cutting-edge research focused on identifying disease-related molecular mechanisms associated with breast disorders, said Dr Richard I. Somiari, the Scientific Director. WRI's close affiliation with Walter Reed Army Medical Center, Washington DC, Uniformed Services University of the Health Sciences The university currently has two mottos: "Learning to Care For Those In Harm's Way" and "Providing Good Medicine In Bad Places." USU School of Medicine With an enrollment of approximately 167 students per class, USU School of Medicine is located in Bethesda, Maryland on the , Bethesda, MD, Windber Medical Center, Windber, the Conemaugh Health System, and all partners in the tissue banking initiative, means that clinically relevant information associated with each specimen is obtained and directly linked with the laboratory data in a central database. About InforMax InforMax (Nasdaq:INMX) is a leading global developer of bioinformatics software for High-Throughput Research(TM). Founded in 1990, today InforMax products are used by 1,870 research organizations and more than 25,000 individual scientists worldwide (as of March 31, 2001) to understand and extract value from the massive amounts of data being generated by the Genomic Revolution. Among the Company's customers are 23 of the top 25 pharmaceutical companies. The Company's mission is to support the scientific community in drug discovery and to better understand the causes of disease. Our High-Throughput Research(TM) and comprehensive suite of bioinformatics software solutions help scientists increase the effectiveness and reduce the time and investment it takes to identify and validate biological targets and discover effective treatments for disease. InforMax bioinformatics software solutions enable a full range of gene-to-genome analysis, interpretation and data mining. Its market-leading products include Vector NTI NTI NewTech Infosystems (software company, Irvine, California) NTI Nuclear Threat Initiative NTI National Transit Institute (New Brunswick, New Jersey) NTI Nunavut Tunngavik Incorporated (R) Suite, the most widely used software suite for enhancing laboratory productivity, and GenoMax (TM) for integrated analysis of genomic and proteomic data. Additional information about InforMax can be found at the Company's Web site at http://www.informaxinc.com. Statements in this press release that are not strictly historical are "forward-looking" statements, which involve a high degree of risk and uncertainty. Such statements are only predictions, and the actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to differences include, but are not limited to, risks associated with InforMax's technologies and the need to keep pace with rapid technological change, the Company's dependence for future revenues on its ability to increase sales of its enterprise platform and successfully establish the GenoMax brand, the Company's dependence on developing and maintaining strategic alliances, development and availability of competitive products or technologies, dependence on patents and the ability to defend the Company's intellectual property rights. These factors and others are more fully described in the Company's annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , as filed with the Securities and Exchange Commission. The Company specifically disclaims any intention or duty to update any forward-looking statements, and these statements represent the Company's current outlook only as of the date given. InforMax, the InforMax logo, Vector NTI, AlignX, BioPlot, and ContigExpress are registered trademarks and GenoMax and High-Throughput Research are trademarks of InforMax, Inc. All other products or company names are used for identification purposes only, and may be the trademarks of their respective owners. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion